It will be interesting to see -To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
1
Favorite

BenjiFuji
08:29

It will be interesting to see the paper for $Moderna, Inc.(MRNA)$ and $Merck(MRK)$ to dive in the details on how good the survival data is. No OS data is also something to take note of.

# Moderna Doubles in a Day on mRNA Cancer Vaccine Data — Still Chaseable?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment（1）

Top
Latest

CornellRudolph
·09:12
PFS can support the story, but OS is still the bar here. Curious how much crossover or follow-up length is masking the signal
Reply
Like
Report

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":598960264253896,"tweetId":"598960264253896","gmtCreate":1787272179831,"gmtModify":1787272737036,"author":{"id":4110175785559852,"idStr":"4110175785559852","authorId":4110175785559852,"authorIdStr":"4110175785559852","name":"BenjiFuji","avatar":"https://community-static.tradeup.com/news/330f59d829009a2c318784ab2b5e6098","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":12,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"1f541396f99840fb977d0ab0ce343c94-1","templateUuid":"1f541396f99840fb977d0ab0ce343c94","name":"Weekly Top Contributor","description":"Contributors with best Editor's Picks every week","bigImgUrl":"https://static.tigerbbs.com/271475ceaf67d40016c8cfa16c08c8b3","smallImgUrl":"https://static.tigerbbs.com/5a6336061b9ba82ba9177c7ec476f5f2","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":3,"allocatedDate":"2022.05.09","individualDisplayEnabled":0},"individualDisplayBadges":[],"wearingBadges":[{"badgeId":"1f541396f99840fb977d0ab0ce343c94-1","name":"Weekly Top Contributor","description":"Contributors with best Editor's Picks every week","smallImgUrl":"https://static.tigerbbs.com/5a6336061b9ba82ba9177c7ec476f5f2","bigImgUrl":"https://static.tigerbbs.com/271475ceaf67d40016c8cfa16c08c8b3","isScarce":0,"effectEnabled":0,"redirectLinkEnabled":0,"redirectLinkValidityFrom":1645614000000,"redirectLinkValidityTo":1742295600000}],"fanSize":699,"starInvestorFlag":false},"themes":[{"themeId":"d1c96f3f846c4c3d95a0606a7ca7d80c","categoryId":"7a15628ce2174325bddc6229505e0d70","name":"Moderna Doubles in a Day on mRNA Cancer Vaccine Data — Still Chaseable?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":d1c96f3f846c4c3d95a0606a7ca7d80c}&rnconfig={\"headerBarHidden\": true}","description":"Moderna +176.97% to $174.38; Merck +12.60%. Their personalized mRNA cancer vaccine intismeran autogene plus Keytruda hit both survival endpoints in the Phase 3 INTerpath-001 melanoma trial — the platform's first Phase 3 oncology win. BofA took its target to $170 from $40, yet the 23-analyst consensus is still Hold at $78.78, most models unrevised. Shorts lost an estimated $4.8bn. Against that: full data unpublished, LTM revenue $2.23bn and falling 27.6%. Chase the platform, buy Merck for the royalty, or wait for the data?","image":"https://community-static.tradeup.com/news/7ad8d816d05c7e50bb31e5798df85288"}],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body>It will be interesting to see the paper for <a href=\"https://ttm.financial/S/MRNA\">$Moderna, Inc.(MRNA)$</a> and <a href=\"https://ttm.financial/S/MRK\">$Merck(MRK)$</a> to dive in the details on how good the survival data is. No OS data is also something to take note of.</body></html>","htmlText":"<html><head></head><body>It will be interesting to see the paper for <a href=\"https://ttm.financial/S/MRNA\">$Moderna, Inc.(MRNA)$</a> and <a href=\"https://ttm.financial/S/MRK\">$Merck(MRK)$</a> to dive in the details on how good the survival data is. No OS data is also something to take note of.</body></html>","text":"It will be interesting to see the paper for $Moderna, Inc.(MRNA)$ and $Merck(MRK)$ to dive in the details on how good the survival data is. No OS data is also something to take note of.","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/598960264253896","repostId":0,"isVote":1,"tweetType":1,"viewCount":53,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["MRK","MRNA"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":151,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":598970348712136,"commentId":"598970348712136","gmtCreate":1787274736696,"gmtModify":1787302367534,"authorId":9000000000000645,"author":{"id":9000000000000645,"idStr":"9000000000000645","authorId":9000000000000645,"name":"CornellRudolph","avatar":"https://static.tigerbbs.com/3f9d9d09b3d77dedfb1d5c351779a212","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":598960264253896,"objectIdStr":"598960264253896","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"PFS can support the story, but OS is still the bar here. Curious how much crossover or follow-up length is masking the signal","text":"PFS can support the story, but OS is still the bar here. Curious how much crossover or follow-up length is masking the signal","html":"PFS can support the story, but OS is still the bar here. Curious how much crossover or follow-up length is masking the signal","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"hasMoreComment":true,"orderType":2}